Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 77045 | |||
| BMT8N | |||
| NCT00186381 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation for AML.
To use high dose chemotherapy with autologous stem cell rescue to try to increase the chance of long term control and cure of the disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| high dose chemotherapy then autologous hematopoietic cell transplant | Procedure |
| Measure | Description | Time Frame |
|---|---|---|
| Disease free survival (DFS) |
| Measure | Description | Time Frame |
|---|---|---|
| Transplant related mortality (TRM) | ||
| Toxicity | ||
| Adequacy of cell collections |
Not provided
Inclusion Criteria:- must be in remission
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Laura Johnston | Stanford University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stanford University School of Medicine | Stanford | California | 94305 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Engraftment kinetics |
| ID | Term |
|---|---|
| D015470 | Leukemia, Myeloid, Acute |
| D007938 | Leukemia |
| ID | Term |
|---|---|
| D007951 | Leukemia, Myeloid |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
Not provided
Not provided